glp 1 discontinuation 🔬 GLP-1/GIP Therapy Discontinuation: Why the “How” Matters One of the most-discussed challenges with GLP-1/GIP agonists such as tirzepatide (Mounjaro®) is weight regain after stopping therapy. What… | Paramesh Shamanna Adding a GLP-1 receptor agonist
Description
Zhang Q et al (2021) The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling
Affordable options for all patients matter, especially when obesity medication isn't always covered by insurance
Sometimes, providers discover it accidentally with imaging tests you get for other reasons
The chemical structures of some DPP4 inhibitors available on the market are presented in Fig
Discuss libido changes with your healthcare provider if decreased sexual desire persists for more than 2-4 weeks or affects your quality of life
